Vice President, Global Scientific Communications

Hybrid$332k – $448k

About this role

Position Summary

Alnylam Pharmaceuticals is seeking an accomplished and visionary Vice President, Global Scientific Communications to lead the strategic development and execution of global scientific communication activities across our portfolio including the ATTR franchise and pipeline assets. Reporting directly to the Sr. Vice President, Head of Medical Affairs, this executive leader will oversee Medical Communications & Publications, Medical Information & Review, Medical Training, and the office of Grants and Sponsorships. They will play a critical role in advancing Alnylam's scientific leadership and reputation among healthcare professionals, researchers, and patient communities.

The successful candidate will be a highly strategic, scientifically sophisticated leader with extensive experience developing and executing integrated medical communication and publication strategies in support of innovative therapies. This individual will partner closely with Clinical Development, Commercial, Regulatory, and Corporate Communications teams to ensure the timely dissemination of high-quality scientific evidence about our products that supports patient care and advances the understanding of disease and treatment.

Key Responsibilities

  • Develop and execute the long term integrated global strategy for Medical Communications, Publications, and Medical Information aligned with Alnylam's corporate and Medical Affairs objectives.
  • Partner as a key member of the Medical Affairs Leadership Team to define strategy and drive organizational development. 
  • Build and retain a best-in-class scientific communications organization recognized for innovation, excellence, compliance, and scientific rigor.
  • Interact with key societies and organizations related to publications and congresses
  • Establish and chair publication governance structures and publication committees.
  • Drive innovation in scientific engagement, digital communications, and omnichannel medical education approaches.
  • Act as a senior scientific representative and thought leader to key external stakeholders. 
  • Foster a culture of scientific excellence, accountability, innovation, collaboration, and continuous learning.
  • Build organizational capabilities to support Alnylam's continued growth and expanding portfolio.

Qualifications

Required

  • Advanced scientific or clinical degree (MD, PharmD, PhD, or equivalent).
  • Minimum of 15 years of progressive experience in Medical Communications, Publications, Medical Affairs, Scientific Communications, or related functions within the pharmaceutical or biotechnology industry.
  • Significant people leadership experience, including management of large, complex, and geographically dispersed teams.
  • Demonstrated success developing and executing global publication and scientific communication strategies.
  • Extensive experience leading publication planning, publication committees, and scientific dissemination activities.
  • Proven expertise in engagement with key opinion leaders, academic investigators, and professional societies.
  • Deep understanding of ICMJE, GPP, publication ethics, authorship standards, and industry regulations.
  • Significant experience planning and leading major international scientific congresses.
  • Strong executive presence and exceptional communication, collaboration, and influencing skills.

Preferred

  • Experience within rare disease, specialty medicine, cardiovascular, neurology, or RNAi therapeutics.
  • Demonstrated success building and transforming high-performing scientific communications organizations.
  • Experience interacting with journal editors, editorial boards, and leading scientific publications.
  • Global experience supporting multiple regions and cross-functional teams.

#LI-JB1 #LI-Hybrid

U.S. Pay Range

$332,000.00 - $448,000.00

The pay range reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus or sales incentive) and an annual long-term incentive award (e.g., equity).

Alnylam’s robust Total Rewards package is designed to support your overall health and well-being. We offer comprehensive benefits including medical, dental, and vision coverage, life and disability insurance, a lifestyle reimbursement program, flexible spending and health savings accounts and a 401(k)with a generous company match. Eligible employees enjoy paid time off, wellness days, holidays, and two company-wide recharge breaks. We also offer generous family resources and leave. Our commitment to your well-being reflects our belief that caring for our people fuels the impact we create together.

Learn more about these and additional benefits offered by Alnylam by visiting the Benefits section of the Careers website: https://www.alnylam.com/careers

About Alnylam

We are the leader in RNAi therapeutics – a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning of what’s possible. Our deep pipeline, late-stage programs, and bold vision reflect our core values: fierce innovation, passion for excellence, purposeful urgency, open culture and commitment to people. We're proud to be a globally recognized top employer, where an authentic, inclusive culture and breakthrough thinking fuel one another.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. Qualified applicants will receive consideration for employment without regard to their sex, gender or gender identity, sexual orientation, race, color, ethnicity, national origin, ancestry, citizenship, religion, creed, physical or mental disability, pregnancy status or related conditions, genetic information, veteran or military status, marital or familial status, political affiliation, age, or any other factor protected by federal, state, or local law. Alnylam is an E-Verify Employer.

Read more

Company at a glance

SILENCE DISEASE. AMPLIFY LIFE.™

Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them.

Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, five more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases.

We are a global and diverse company of 2,600+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-25), Science Magazine (2018-25), Fast Company (Best Workplaces for Innovators 2020-25) and Great Place to Work.

We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America.

See our social media community guidelines: https://bit.ly/2FcRhJy.

Please note: If you wish to report an adverse event or product complaint, please email [email protected] or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Fraudulent Recruitment Activity

Be aware of the potential for scams and fraudulent recruitment activity from individuals claiming to represent Alnylam Pharmaceuticals. Alnylam never conducts its interview process via messaging apps, freelance sites, or social media platforms. Alnylam team members only communicate with potential candidates through an official Alnylam email address ending in "@alnylam.com."

Founded2002
Team Size1,001-5,000 employees
WorkspaceHybrid
IndustryBiotechnology Research
Location
Cambridge, Massachusetts, United States
LinkedInLinkedIn

Top Benefits

  • Medical Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • Lifestyle Reimbursement Program
  • Flexible Spending Account
  • Health Savings Account
  • 401(k) With Company Match
  • Paid Time Off
  • Wellness Days
  • Holidays
  • Company-wide Recharge Breaks
  • Family Resources
  • Family Leave
  • Annual Short-term Incentive Award
  • Annual Long-term Incentive Award

Tired of cold applications?

Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.

Know someone who'd be great for this?